1887

Journal of Medical Microbiology logo

Volume 68, Issue 6

Circulation of imipenem-resistant Acinetobacter baumannii ST10, ST2 and ST3 in a university teaching hospital from Tehran, Iran Free

Abstract

Purpose. Multi-drug resistant (MDR) Acinetobacter baumannii has introduced a worldwide health crisis. The purposes of this study were to characterize the clonal relatedness among MDR clinical strains and to introduce a new two-locus typing method confirmed by multi-locus sequence typing (MLST).

Methodology. In this study, we determined antimicrobial resistance, detected genes associated with carbapenem resistance and characterized clonal relatedness among 99 clinical isolates extracted from 82 hospitalized inpatients in a university hospital.

Results. Of the 99 A. baumannii isolates, 92.9% (92/99) were resistant to imipenem and 97.9% (97/99) had an MDR profile. We found that the high prevalence of blaVIM [94.9% (94/99)] and blaOXA-23-like [93.93% (93/99)] is the main mechanism of carbapenem resistance. This study proposes a new two-locus typing (blaOXA-51-like and ampC) method for the rapid identification of clonal complexes (CCs). The results of this method and confirmation by MLST show that clinical isolates carry blaOXA-68 as well as ampC-10 or ampC-20 genes belonging to CC10 (ST10); blaOXA-66 and ampC-2 belonging to CC2 (ST2); and blaOXA-71 and ampC-3 belonging to CC3 (ST3). One isolate had blaOXA-90 with an undetermined allele number of ampC belonging to ST513.

Conclusion. The high prevalence of MDR strains and the circulation of four limited clones, including ST10 (45/99), ST2 (41/99), ST3 (12/99) and ST513 (1/99), in the clinical setting highlights the importance of a rigorous infection control programme. The two-locus typing method has more discrimination than the application of each method separately and it could be applied for the rapid determination of the CC without performing MLST.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): carbapenemase genes , clonal relatedness and Multi-drug resistant (MDR) Acinetobacter baumannii
© 2019 The Authors
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000987
2019-05-03
2024-04-27
Loading full text...

Full text loading...

/deliver/fulltext/jmm/68/6/860.html?itemId=/content/journal/jmm/10.1099/jmm.0.000987&mimeType=html&fmt=ahah

References

  1. Wong D, Nielsen TB, Bonomo RA, Pantapalangkoor P, Luna B et al. Clinical and pathophysiological overview of Acinetobacter infections: a century of challenges. Clin Microbiol Rev 2017; 30:409–447
     [Google Scholar]
  2. Özgür ES, Horasan ES, Karaca K, Ersöz G, Naycı Atış S et al. Ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii: risk factors, clinical features, and outcomes. Am J Infect Control 2014; 42:206–208 [View Article]
     [Google Scholar]
  3. Chaari A, Mnif B, Bahloul M, Mahjoubi F, Chtara K et al. Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors. Int J Infect Dis 2013; 17:e1225–e1228 [View Article]
     [Google Scholar]
  4. Lee CR, Lee JH, Park M, Park KS, Bae IK et al. Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options. Front Cell Infect Microbiol 2017; 7:55 [View Article]
     [Google Scholar]
  5. Evans BA, Hamouda A, Amyes SGB. The rise of carbapenem-resistant Acinetobacter baumannii. Curr Pharm Des 2013; 19:223–238 [View Article]
     [Google Scholar]
  6. Higgins PG, Dammhayn C, Hackel M, Seifert H. Global spread of carbapenem-resistant Acinetobacter baumannii. J Antimicrob Chemother 2010; 65:233–238 [View Article]
     [Google Scholar]
  7. Chuang YC, Cheng A, Sun HY, Wang JT, Chen YC et al. Microbiological and clinical characteristics of Acinetobacter baumannii bacteremia: Implications of sequence type for prognosis. J Infect 2019; 78:106–112 [View Article]
     [Google Scholar]
  8. Zarrilli R, Pournaras S, Giannouli M, Tsakris A. Global evolution of multidrug-resistant Acinetobacter baumannii clonal lineages. Int J Antimicrob Ag 2013; 41:11–19 [View Article]
     [Google Scholar]
  9. Tomaschek F, Higgins PG, Stefanik D, Wisplinghoff H, Seifert H. Head-to-head comparison of two multi-locus sequence typing (MLST) schemes for characterization of Acinetobacter baumannii outbreak and sporadic isolates. Plos One 2016; 11:e0153014 [View Article]
     [Google Scholar]
  10. Martín-Aspas A, Guerrero-Sánchez FM, García-Colchero F, Rodríguez-Roca S, Girón-González JA. Differential characteristics of Acinetobacter baumannii colonization and infection: risk factors, clinical picture, and mortality. Infect Drug Resist 2018; 11:861
     [Google Scholar]
  11. Lee MJ, Jang SJ, Li XM, Park G, Kook JK et al. Comparison of rpoB gene sequencing, 16S rRNA gene sequencing, gyrB multiplex PCR, and the VITEK2 system for identification of Acinetobacter clinical isolates. Diagn Microbiol Infect Dis 2014; 78:29–34 [View Article]
     [Google Scholar]
  12. Magiorakos AP, Srinivasan A, Carey RB, Carmeli Y, Falagas ME et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18:268–281 [View Article]
     [Google Scholar]
  13. Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing, 28th ed. CLSI supplement M100. Wayne, PA: Clinical and Laboratory Standards Institute; 2018
     [Google Scholar]
  14. Gräser Y, Klare I, Halle E, Gantenberg R, Buchholz P et al. Epidemiological study of an Acinetobacter baumannii outbreak by using polymerase chain reaction fingerprinting. J Clin Microbiol 1993; 31:2417–2420
     [Google Scholar]
  15. Pournaras S, Gogou V, Giannouli M, Dimitroulia E, Dafopoulou K et al. Single-locus-sequence-based typing of blaOXA-51-like genes for rapid assignment of Acinetobacter baumannii clinical isolates to international clonal lineages. J Clin Microbiol 2014; 52:1653–1657 [View Article]
     [Google Scholar]
  16. Karah N, Jolley KA, Hall RM, Uhlin BE. Database for the ampC alleles in Acinetobacter baumannii. Plos One 2017; 12:e0176695 [View Article]
     [Google Scholar]
  17. Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H. OXA-143, a novel carbapenem-hydrolyzing class D beta-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother 2009; 53:5035–5038 [View Article]
     [Google Scholar]
  18. Mirshekar M, Shahcheraghi F, Azizi O, Solgi H, Badmasti F. Diversity of class 1 integrons, and disruption of carO and dacD by insertion sequences among Acinetobacter baumannii isolates in Tehran, Iran. Microb Drug Resist 2018; 24:359–366 [View Article]
     [Google Scholar]
  19. El-Shazly S, Dashti A, Vali L, Bolaris M, Ibrahim AS. Molecular epidemiology and characterization of multiple drug-resistant (MDR) clinical isolates of Acinetobacter baumannii. Int J Infect Dis 2015; 41:42–49 [View Article]
     [Google Scholar]
  20. Piran A, Shahcheraghi F, Solgi H, Rohani M, Badmasti F. A reliable combination method to identification and typing of epidemic and endemic clones among clinical isolates of Acinetobacter baumannii. Infect Genet Evol 2017; 54:501–507 [View Article]
     [Google Scholar]
  21. Diancourt L, Passet V, Nemec A, Dijkshoorn L, Brisse S. The population structure of Acinetobacter baumannii: expanding multiresistant clones from an ancestral susceptible genetic pool. PLoS One 2010; 5:e10034 [View Article]
     [Google Scholar]
  22. Ellis D, Cohen B, Liu J, Larson E. Risk factors for hospital-acquired antimicrobial-resistant infection caused by Acinetobacter baumannii. Antimicrob Resist Infect Control 2015; 4:40 [View Article]
     [Google Scholar]
  23. Kucukler E. Risk factors of Acinetobacter baumannii infections. Int J Infect Dis 2014; 21:420 [View Article]
     [Google Scholar]
  24. Davoudi-Monfared E, Khalili H. The threat of carbapenem-resistant Gram-negative bacteria in a middle East region. Infect Drug Resist 2018; 11:1831–1880 [View Article]
     [Google Scholar]
  25. Shahcheraghi F, Abbasalipour M, Feizabadi M, Ebrahimipour G, Akbari N. Isolation and genetic characterization of metallo-β-lactamase and carbapenamase producing strains of Acinetobacter baumannii from patients at Tehran hospitals. Iran J Microbiol 2011; 3:68
     [Google Scholar]
  26. Mugnier PD, Poirel L, Naas T, Nordmann P. Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg Infect Dis 2010; 16:35
     [Google Scholar]
  27. Armin S, Fallah F, Azimi L, Samadi Kafil H, Ghazvini K et al. Warning: spread of NDM-1 in two border towns of Iran. Cell Mol Biol 2018; 64:125–129 [View Article]
     [Google Scholar]
  28. Ou HY, Kuang SN, He X, Molgora BM, Ewing PJ et al. Complete genome sequence of hypervirulent and outbreak-associated Acinetobacter baumannii strain LAC-4: epidemiology, resistance genetic determinants and potential virulence factors. Sci Rep 2015; 5:8643 [View Article]
     [Google Scholar]
  29. Evans BA, Hamouda A, Towner KJ, Amyes GB. OXA-51-like β-lactamases and their association with particular epidemic lineages of Acinetobacter baumannii. Clin Microbiol Infec 2008; 14:268–275 [View Article]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000987
Loading
Circulation of imipenem-resistant Acinetobacter baumannii ST10, ST2 and ST3 in a university teaching hospital from Tehran, Iran
J. Med. Microbiol. 68, 860 (2019); https://doi.org/10.1099/jmm.0.000987
/content/journal/jmm/10.1099/jmm.0.000987
/content/journal/jmm/10.1099/jmm.0.000987
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error